|
|
|
|
|
1.
1442 Accesses
|
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
Gerhard J Molderings, Stefan Brettner, Jürgen Homann, Lawrence B Afrin Journal of Hematology & Oncology 2011, 4:10 (22 March 2011)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
2.
1218 Accesses
|
MEK and the inhibitors: from bench to bedside
Akintunde Akinleye, Muhammad Furqan, Nikhil Mukhi, Pavan Ravella, Delong Liu Journal of Hematology & Oncology 2013, 6:27 (12 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed | Cited on BioMed Central
|
|
|
3.
1192 Accesses
|
Clinical applications of mesenchymal stem cells
Shihua Wang, Xuebin Qu, Robert Zhao Journal of Hematology & Oncology 2012, 5:19 (30 April 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
4.
1063 Accesses
|
The effects of β-glucan on human immune and cancer cells
Godfrey Chan, Wing Chan, Daniel Sze Journal of Hematology & Oncology 2009, 2:25 (10 June 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
5.
916 Accesses
|
The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
Saad Z Usmani, Robert D Bona, Gabriela Chiosis, Zihai Li Journal of Hematology & Oncology 2010, 3:40 (26 October 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
6.
887 Accesses
|
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
Lieke H van der Helm, Ellen RM Scheepers, Nic JGM Veeger, Simon MGJ Daenen, André B Mulder, Eva van den Berg, Edo Vellenga, Gerwin Huls Journal of Hematology & Oncology 2013, 6:29 (16 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
7.
782 Accesses
|
Targeted drug delivery for cancer therapy: the other side of antibodies
Michael A Firer, Gary Gellerman Journal of Hematology & Oncology 2012, 5:70 (9 November 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
8.
766 Accesses
|
B-Raf and the inhibitors: from bench to bedside
Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong, Delong Liu Journal of Hematology & Oncology 2013, 6:30 (25 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
9.
749 Accesses
|
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang, Xiao-feng Yang Journal of Hematology & Oncology 2013, 6:19 (25 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
10.
719 Accesses
|
Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
Lisa Pleyer, Reinhard Stauder, Sonja Burgstaller, Martin Schreder, Christoph Tinchon, Michael Pfeilstocker, Susanne Steinkirchner, Thomas Melchardt, Martina Mitrovic, Michael Girschikofsky, Alois Lang, Peter Krippl, Thamer Sliwa, Alexander Egle, Werner Linkesch, Daniela Voskova, Hubert Angermann, Richard Greil Journal of Hematology & Oncology 2013, 6:32 (29 April 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
11.
670 Accesses
|
Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature
Utkarsh Acharya, Jen-Tzer Gau, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen Journal of Hematology & Oncology 2008, 1:26 (18 December 2008)
Abstract | Full text | PDF
| PubMed
|
|
|
12.
662 Accesses
|
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
Jie Li, Oluwole Fadare, Li Xiang, Beihua Kong, Wenxin Zheng Journal of Hematology & Oncology 2012, 5:8 (9 March 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
13.
618 Accesses
|
Mechanism of action of lenalidomide in hematological malignancies
Venumadhav Kotla, Swati Goel, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das, Amit Verma Journal of Hematology & Oncology 2009, 2:36 (12 August 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
14.
616 Accesses
|
De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome
Xiao Min, Zhang Na, Liu Yanan, Li Chunrui Journal of Hematology & Oncology 2011, 4:45 (10 November 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
15.
598 Accesses
|
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition
Beverly L Falcon, Belinda O’Clair, Don McClure, Glenn F Evans, Julie Stewart, Michelle L Swearingen, Yuefeng Chen, Kevin Allard, Linda N Lee, Kuldeep Neote, Dyke P McEwen, Mark T Uhlik, Sudhakar Chintharlapalli Journal of Hematology & Oncology 2013, 6:31 (27 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
16.
519 Accesses
|
Light chain (AL) amyloidosis: update on diagnosis and management
Michael Rosenzweig, Heather Landau Journal of Hematology & Oncology 2011, 4:47 (18 November 2011)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
17.
514 Accesses
|
Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia
Maoxiang Qian, Wen Jin, Xuehua Zhu, Xiaohong Jia, Xianwen Yang, Yanzhi Du, Kankan Wang, Ji Zhang Journal of Hematology & Oncology 2013, 6:25 (2 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
18.
496 Accesses
|
Targeting p53 by small molecules in hematological malignancies
Manujendra N Saha, Lugui Qiu, Hong Chang Journal of Hematology & Oncology 2013, 6:23 (27 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
19.
477 Accesses
|
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia
Oumar Samassekou, Abba Malina, Josée Hébert, Ju Yan Journal of Hematology & Oncology 2013, 6:26 (2 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
20.
478 Accesses
|
Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen
Yan Zhuang, Xiang Wang, Hong T Nguyen, Ying Zhuo, Xinpeng Cui, Claire Fewell, Erik K Flemington, Bin Shan Journal of Hematology & Oncology 2013, 6:35 (13 May 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
21.
477 Accesses
|
The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia
Andreia Maria Camargos Rocha, Cláudia Souza, Gifone Aguiar Rocha, Fabrício Freire de Melo, Nelma Cristina Diogo Clementino, Marília Campos Abreu Marino, Dulciene Maria Magalhães Queiroz Journal of Hematology & Oncology 2013, 6:28 (12 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
22.
452 Accesses
|
Therapeutic advancement of chronic lymphocytic leukemia
Kang Lu, Xin Wang Journal of Hematology & Oncology 2012, 5:55 (16 September 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
23.
432 Accesses
|
Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects
Mazin A Zamzami, John A Duley, Gareth R Price, Deon J Venter, John W Yarham, Robert W Taylor, Laurence P Catley, Timothy HJ Florin, Anthony M Marinaki, Francis Bowling Journal of Hematology & Oncology 2013, 6:24 (29 March 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
24.
419 Accesses
|
Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis
Bernardo HL Goulart, Jeffrey W Clark, Gregory Y Lauwers, David P Ryan, Nina Grenon, Alona Muzikansky, Andrew X Zhu Journal of Hematology & Oncology 2009, 2:13 (16 March 2009)
Abstract | Full text | PDF
| PubMed
|
|
|
25.
421 Accesses
|
Chemotherapy in advanced bladder cancer: current status and future
Nabil Ismaili, Mounia Amzerin, Aude Flechon Journal of Hematology & Oncology 2011, 4:35 (9 September 2011)
Abstract | Full text | PDF
| PubMed
|